Vidali, S. ; Gerlini, R. ; Thompson, K.* ; Urquhart, J.E.* ; Meisterknecht, J.* ; Aguilar-Pimentel, J.A. ; Amarie, O.V. ; Becker, L. ; Breen, C.* ; Calzada-Wack, J. ; Chhabra, N.F. ; Cho, Y.-L. ; da Silva Buttkus, P. ; Feichtinger, R.G.* ; Gampe, K. ; Garrett, L. ; Hoefig, K.P. ; Hölter, S.M. ; Jameson, E.* ; Klein-Rodewald, T. ; Leuchtenberger, S. ; Marschall, S. ; Mayer-Kuckuk, P. ; Miller, G. ; Oestereicher, M.A. ; Pfannes, K. ; Rathkolb, B. ; Rozman, J. ; Sanders, C.* ; Spielmann, N. ; Stoeger, C. ; Szibor, M.* ; Treise, I. ; Walter, J.H.* ; Wurst, W. ; Mayr, J.A.* ; Fuchs, H. ; Gärtner, U.* ; Wittig, I.* ; Taylor, R.W.* ; Newman, W.G.* ; Prokisch, H. ; Gailus-Durner, V. ; Hrabě de Angelis, M.
Characterising a homozygous two-exon deletion in UQCRH: Comparing human and mouse phenotypes.
EMBO Mol. Med.:e14397 (2021)
Mitochondrial disorders are clinically and genetically diverse, with isolated complex III (CIII) deficiency being relatively rare. Here, we describe two affected cousins, presenting with recurrent episodes of severe lactic acidosis, hyperammonaemia, hypoglycaemia and encephalopathy. Genetic investigations in both cases identified a homozygous deletion of exons 2 and 3 of UQCRH, which encodes a structural complex III (CIII) subunit. We generated a mouse model with the equivalent homozygous Uqcrh deletion (Uqcrh−/−), which also presented with lactic acidosis and hyperammonaemia, but had a more severe, non-episodic phenotype, resulting in failure to thrive and early death. The biochemical phenotypes observed in patient and Uqcrh−/− mouse tissues were remarkably similar, displaying impaired CIII activity, decreased molecular weight of fully assembled holoenzyme and an increase of an unexpected large supercomplex (SXL), comprising mostly of one complex I (CI) dimer and one CIII dimer. This phenotypic similarity along with lentiviral rescue experiments in patient fibroblasts verifies the pathogenicity of the shared genetic defect, demonstrating that the Uqcrh−/− mouse is a valuable model for future studies of human CIII deficiency.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Complex Iii ; Mitochondrial Disease ; Mouse Model ; Oxphos ; Uqcrh; Complex-iii Deficiency; Mitochondrial-dna; Gracile Syndrome; Lactic-acidosis; Mutation; Patient; Disease; Gene; Identification; Lyrm7/mzm1l
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
1757-4676
e-ISSN
1757-4684
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: ,
Heft: ,
Seiten: ,
Artikelnummer: e14397
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
Chichester
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30205 - Bioengineering and Digital Health
30203 - Molecular Targets and Therapies
30204 - Cell Programming and Repair
Forschungsfeld(er)
Genetics and Epidemiology
Immune Response and Infection
PSP-Element(e)
G-500600-001
G-501900-063
G-503292-001
G-500692-001
G-500600-003
G-501712-001
G-500500-001
Förderungen
Lily Foundation
Austrian Science Fund (FWF)
Deutsche Forschungsgemeinschaft (DFG)
UKRI | MRC | Medical Research Foundation
Action Medical Research (AMR)
NIHR Bristol Biomedical Research Centre (Bristol BRC)
Newcastle upon Tyne Hospitals NHS Foundation Trust (Newcastle upon Tyne Hospitals NHS Trust)
Mitochondrial Disease Patient Cohort (UK)
German Center for Diabetes Research (DZD)
Copyright
Erfassungsdatum
2021-11-15